Prognosis
Covid-19 Vaccine Expectations May Be Getting Ahead of Science
- SVB Leerink, Roche warn on optimism over vaccine timing
- Too-fast development could come with risks, analyst says
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
A recovering U.S. stock market may be pricing in too much optimism over the near-term potential of a vaccine to prevent the spread of the novel coronavirus.